Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Apilimod
2. Apilimod Bis-mesylate
3. Apilimod Bismesylate
4. Apilimod Dimesylate
5. Apilimod Mesilate
6. Sta 5326
7. Sta 5326 Mesilate
8. Sta 5326 Mesylate
9. Sta-5326
10. Sta-5326 Mesilate
11. Sta-5326 Mesylate
12. Sta5326
1. 870087-36-8
2. Apilimod Dimesylate
3. Sta-5326 Mesylate
4. Sta 5326 Mesylate
5. Apilimod Mesylate [usan]
6. (e)-4-(6-(2-(3-methylbenzylidene)hydrazinyl)-2-(2-(pyridin-2-yl)ethoxy)pyrimidin-4-yl)morpholine Dimethanesulfonate
7. 5g3p5ok11s
8. Apilimod (mesylate)
9. Apilimod Mesylate (usan)
10. Methanesulfonic Acid;n-[(e)-(3-methylphenyl)methylideneamino]-6-morpholin-4-yl-2-(2-pyridin-2-ylethoxy)pyrimidin-4-amine
11. Apilimod Mesilate
12. 4-(6-(2-(3-methylbenzylidene)hydrazinyl)-2-(2-(pyridin-2-yl)ethoxy)pyrimidin-4-yl)morpholine Dimethanesulfonate
13. Benzaldehyde, 3-methyl-, (6-(4-morpholinyl)-2-(2-(2-pyridinyl)ethoxy)-4-pyrimidinyl)hydrazone, Dimethanesulfonate
14. Apilimod Bis-mesylate
15. Sta 5326 Mesilate
16. Sta-5326 Mesilate
17. Unii-5g3p5ok11s
18. Sta 5326 Dimesylate
19. Schembl3082380
20. Ex-a909
21. Apilimod Dimesylate [who-dd]
22. Hy-14644a
23. Mfcd28167749
24. As-16911
25. Ba177431
26. S0785
27. D06556
28. A931017
29. J-690369
30. 2-(5-chloro-2-{[3-(4-methyl-1-piperazinyl)propyl]amino}-4-pyrimidinyl)-n-cyclopropyl-1-benzothiophene-4-carboxamide
31. Benzaldehyde, 3-methyl-, (6-(4-morpholinyl)-2-(2-(2-pyridinyl)ethoxy)-4-pyrimidinyl)hydrazone Mesilate
32. Benzaldehyde, 3-methyl-, (6-(4-morpholinyl)-2-(2-(2-pyridinyl)ethoxy)-4-pyrimidinyl)hydrazone Mesylate
33. Benzaldehyde, 3-methyl-, (6-(4-morpholinyl)-2-(2-(2-pyridinyl)ethoxy)-4-pyrimidinyl)hydrazone, Dimethanesulphonate
34. Benzaldehyde, 3-methyl-, 2-(6-(4-morpholinyl)-2-(2-(2-pyridinyl)ethoxy)-4-pyrimidinyl)hydrazone Methanesulfonate (1:2)
35. Benzaldehyde, 3-methyl-, 2-(6-(4-morpholinyl)-2-(2-(2-pyridinyl)ethoxy)-4-pyrimidinyl)hydrazone Methanesulphonate (1:2)
36. Benzaldehyde, 3-methyl-,[6-(4-morpholinyl)-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl]hydrazone,dimethanesulfonate
37. N-(3-methylbensylidene) N-(6-morpholin-4-yl-2(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl)-hydrazine Bismesilate
38. N-(3-methylbensylidene) N-(6-morpholin-4-yl-2(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl)-hydrazine Bismesylate
39. N-(3-methylbensylidene) N?-(6-morpholin-4-yl-2(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl)-hydrazine Bismesylate
| Molecular Weight | 610.7 g/mol |
|---|---|
| Molecular Formula | C25H34N6O8S2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 8 |
| Exact Mass | 610.18795441 g/mol |
| Monoisotopic Mass | 610.18795441 g/mol |
| Topological Polar Surface Area | 210 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 637 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
62
PharmaCompass offers a list of Apilimod mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Apilimod mesylate manufacturer or Apilimod mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Apilimod mesylate manufacturer or Apilimod mesylate supplier.
PharmaCompass also assists you with knowing the Apilimod mesylate API Price utilized in the formulation of products. Apilimod mesylate API Price is not always fixed or binding as the Apilimod mesylate Price is obtained through a variety of data sources. The Apilimod mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Apilimod mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apilimod mesylate, including repackagers and relabelers. The FDA regulates Apilimod mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apilimod mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Apilimod mesylate supplier is an individual or a company that provides Apilimod mesylate active pharmaceutical ingredient (API) or Apilimod mesylate finished formulations upon request. The Apilimod mesylate suppliers may include Apilimod mesylate API manufacturers, exporters, distributors and traders.
Apilimod mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apilimod mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apilimod mesylate GMP manufacturer or Apilimod mesylate GMP API supplier for your needs.
A Apilimod mesylate CoA (Certificate of Analysis) is a formal document that attests to Apilimod mesylate's compliance with Apilimod mesylate specifications and serves as a tool for batch-level quality control.
Apilimod mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Apilimod mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apilimod mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Apilimod mesylate EP), Apilimod mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apilimod mesylate USP).
